A systematic review describing incidence rate and prevalence of dysvascular partial foot amputation; how both have changed over time and compare to transtibial amputation

Dillon, Michael P; Quigley, Matthew; Fatone, Stefania

doi:10.1186/s13643-017-0626-0

Systematic Reviews

Table 2 Demographic information

From: A systematic review describing incidence rate and prevalence of dysvascular partial foot amputation; how both have changed over time and compare to transtibial amputation

Author		Partial foot amputation				Transtibial amputation				A	B	C	D	E	F	G	H	I	J	K	L	M	O
	Years	(n)	DM	Male	Age	(n)	DM	Male	Age
	Years	(n)	(%)	(%)	M(SD)	(n)	(%)	(%)	M(SD)
Almaraz et al. [39]	9	7007	73^a	66^a	68.6(11.5)^a										X
Alvarsson et al. [52]	6	46	76	55^a	81^a	109	62	55^	81^						X				X		X		X
Buckley et al. [50]	5	NR	54^a	NR	NR
Canavan et al. [43]	5^b	NR	49^a	66^a	73% < 60					X		X			X							X	X
Davis et al. [36]	9	43	100	59^c	66.8(9.3)	13	100	59^c	66.8(9.3)					X	X	X	X	X	X	X	X		X
Dillingham et al. [48]	12	8684^d	43^a	54^a	67.7(14.7)^a	6883	43^a	54^a	67.7(14.7)^a	X					X	X							X
Feinglass et al. [13]	18	5733^e	80	65	64.9(12.9)	14,801	70	56	68.8(12.8)	X	X				X								X
Kennon et al. [51]	5	1023	NR	NR	NR
Krishnan et al. [44]	11	NR	NR	NR	70.7^a
Kurowski et al. [38]	11	3796	64^a	66^a	65^a					X			X		X		X	X		X	X		X
Lai et al. [53]	11	776	100	NR	NR
Lazzarini et al. [37]	6	3009	100	71	64(median)
Lombardo et al. [9]	8	51,253	68^a	NR	71.1(11.1)^f
Lopez-de-Andres et al. [41]	7	46,536	80	74	66.9(14.6)										X
Lopez-de-Andres et al. [42]	11	73,302	75	75	66										X	X
Rayman et al. [45]	3	34	100	NR	NR
Rubio et al. [40]	11	248	73	69^g	71^g
Sandnes et al. [49]	14	4434	66	61	66(15.5)										X	X				X
Valabhji et al. [46]	5	34	NR	76	68(11)										X				X	X	X
Vamos et al. [47]	10	S^h	S^h	S^h	S^h						X				X
Vamos et al. [7]	5	S^h	S^h	S^h	S^h						X				X
Ziegler-Graham et al. [2]	1	NR	NR	NR	NR

Years years included in timeseries; DM diabetes mellitus; M(SD) mean (standard deviation); PFA partial foot amputation; TTA transtibial amputation; NR not reported; A race/ethnicity; B sociodemographic: include education level, relationship status, employment status, residential status, geographic region, economic status; C tobacco use; D other lifestyle behaviors include alcohol use and malnutrition; E BMI: body mass index, F diabetes, G comorbidities include the Charlson comorbidity index, frequency of comorbidities and the Anesthesiology Association of America Physical Status scale; H blood pressure; I other blood flow/pressure issues: include missing pulses, ankle brachial index, Doppler for ankle blood pressure; J coronary artery disease or cerebrovascular accident; K other cardiovascular problems include cardiovascular disease, myocardial infarct, heart attack, peripheral arterial disease, peripheral vascular disease, and chronic obstructive pulmonary disease; L renal issues include nephropathy, renal dialysis, chronic renal failure, renal insufficiency, and end-stage renal disease; M reamputation; O other includes ulcer, diabetes with end organ damage, and zip code
^aBased on lower limb sample as a whole
^bDuration of study: 5 years; data reported for 3 years
^cFor those with diabetes-related amputation
^dToe level only; ‘foot’ amputations excluded due to inclusion of ankle disarticulation
^e‘Through foot’—excludes toe only amputations
^fFor people with diabetes in 2010
^gWeighted average
^hStratified by proportions with and without diabetes; this information is presented in full in the appendix

Back to article page

ISSN: 2046-4053

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com